TRAX (First Tracks Biotherapeutics) Cash Flow for Dividends: $0.00 Mil (TTM As of Dec. 2024)

What is First Tracks Biotherapeutics Cash Flow for Dividends?

First Tracks Biotherapeutics TRAX -3.75% 12 Cash Flow for Dividends is $0.00 Mil as of Dec. 2024. GuruFocus rates TRAX with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

First Tracks Biotherapeutics's cash flow for dividends for the six months ended in Dec. 2024 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

First Tracks Biotherapeutics Cash Flow for Dividends Related Terms

First Tracks Biotherapeutics Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics Cash Flow for Dividends Chart

First Tracks Biotherapeutics Annual Data

Trend

Dec23

Dec24

Cash Flow for Dividends

0.00

First Tracks Biotherapeutics Semi-Annual Data
	Dec23	Dec24
Cash Flow for Dividends	0.00	0.00

12GF Score

First Tracks Biotherapeutics Inc TRAX

Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

First Tracks Biotherapeutics Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Frequently Asked Questions Learn more about Cash Flow for Dividends →

What does a Cash Flow for Dividends of $0.00 Mil mean?

First Tracks Biotherapeutics (TRAX) has a Cash Flow for Dividends of $0.00 Mil as of Dec. 2024. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for First Tracks Biotherapeutics and its competitors.

Is First Tracks Biotherapeutics' Cash Flow for Dividends too high?

First Tracks Biotherapeutics' current Cash Flow for Dividends is $0.00 Mil. Overall, First Tracks Biotherapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does First Tracks Biotherapeutics' Cash Flow for Dividends compare to ALT and RGNX?

First Tracks Biotherapeutics' Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash Flow for Dividends for a Biotechnology company?

A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash Flow for Dividends mean?

A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for First Tracks Biotherapeutics and its competitors. First Tracks Biotherapeutics's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is First Tracks Biotherapeutics stock overvalued right now?

First Tracks Biotherapeutics (TRAX) has a current Cash Flow for Dividends of $0.00 Mil. The current Cash Flow for Dividends is $0.00 Mil. First Tracks Biotherapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash Flow for Dividends calculated?

Cash Flow for Dividends is calculated from a company's financial statements. For First Tracks Biotherapeutics (TRAX), the current Cash Flow for Dividends is $0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

First Tracks Biotherapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies ALT RGNX MDXG MNPR ASMB FTH CTNM BBOT PRTA TECX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges B43:Germany

Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

12GF Score

Get the complete analysis for TRAX

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.88

Price

View TRAX Analysis

See Cash Flow for Dividends data for all stocks →